American Journal of Physiology-Gastrointestinal and Liver Physiology Podcast

ajpgi

Podcasts of the American Journal of Physiology-Gastrointestinal and Liver Physiology

  1. 09/08/2025

    Cinnabarinic acid protects against metabolic dysfunction-associated steatohepatitis by activating Aryl hydrocarbon Receptor-dependent AMPK signaling

    In this episode, Dr. Aditya Joshi and coauthors discuss their team’s recently published study, “Cinnabarinic acid protects against metabolic dysfunction-associated steatohepatitis by activating Aryl hydrocarbon Receptor-dependent AMPK signaling." The study showed that absence of AhR in hepatocytes results in exacerbated metabolic dysfunction-associated steatohepatitis (MASH) in mice subjected to Western-style high-fat high-fructose high-cholesterol diet. Moreover, treatment with a tryptophan catabolite, cinnabarinic acid (CA) mitigated hallmarks of MASH in an AhR-dependent manner. In conclusion, the study delineates the significance of hepatic AhR-dependent AMPK signaling in CA-mediated protection against MASH.   Cinnabarinic acid protects against metabolic dysfunction-associated steatohepatitis by activating Aryl hydrocarbon Receptor-dependent AMPK signaling. Nikhil Y. Patil, Iulia Rus, Felix Ampadu, Hassan M. Abu Shukair, Sarah Bonvicino, Richard S. Brush, Elena Eaton, Martin-Paul Agbaga, Tae Gyu Oh, Jacob E. Friedman, and Aditya D. Joshi 2025 329:4, G433-G447

    9 min

  2. 07/24/2025

    Uncovering the Gut-Adipose-Liver Axis: Microbiota Encroachment and Metabolic Dysfunction in MASLD

    In this episode, coauthors Daria Igudesman and Karen D. Corbin discuss their team’s recently published study, "Microbiota encroachment and a gut-adipose-liver axis in metabolic dysfunction-associated steatotic liver disease." This first-in-human study explores how changes in the gut microbiota may contribute to metabolic dysfunction through a gut-adipose-liver axis. The researchers found that colonic expression of insulin and lipid-related genes may link microbial encroachment in the colon with adipose tissue insulin resistance and the development of metabolic dysfunction-associated steatotic liver disease (MASLD). Tune in to learn how these findings offer new insights into the complex interplay between the gut microbiome and metabolic health.   Microbiota encroachment and a gut-adipose-liver axis in metabolic dysfunction-associated steatotic liver disease Daria Igudesman, GongXin Yu, Charlene Dauriat, Torfay Roman, Maryam R. Kashi, Elizabeth Blakley, Benoit Chassaing, and Karen D. Corbin American Journal of Physiology-Gastrointestinal and Liver Physiology 2025 329:1, G201-G214

    10 min

  3. 07/24/2025

    Modeling Eosinophilic Esophagitis: Insights from Mouse Models into Mechanisms and Therapies

    In this episode, coauthors Jazmyne L. Jackson, Abigail J. Staub, Annie D. Fuller, and Kelly A. Whelan join us to discuss their recently published review, "Mouse models of eosinophilic esophagitis: molecular and translational insights." Eosinophilic esophagitis (EoE) is a chronic allergic inflammatory disease of the esophagus with growing prevalence and clinical impact, yet many of its underlying mechanisms remain poorly understood. The authors explore how murine models have advanced our knowledge of EoE pathogenesis, highlighting key molecular and translational findings uncovered through in vivo research. This episode delves into the strengths and limitations of existing models, current challenges, and future opportunities for leveraging mouse models to guide diagnosis, monitoring, and therapy development in EoE.   Mouse models of eosinophilic esophagitis: molecular and translational insights Jazmyne L. Jackson, Abigail J. Staub, Annie D. Fuller, John M. Crespo, Travis H. Bordner, Courtney Worrell, No’ad Shanas, Danielle Waheed, Tatiana A. Karakasheva, Melanie Ruffner, Amanda B. Muir, and Kelly A. Whelan American Journal of Physiology-Gastrointestinal and Liver Physiology 2025 329:1, G215-G231

    11 min

  4. 07/24/2025

    Probiotics, Tryptophan, and Gut Health: How L. rhamnosus GG Remodels Arginine Metabolism to Protect the Barrier

    In this episode, Jayson M. Antonio and Ronaldo P. Ferraris discuss their team’s recently published study, "Lacticaseibacillus rhamnosus GG-driven remodeling of arginine metabolism mitigates gut barrier dysfunction." The research reveals a novel probiotic-driven mechanism that links dietary tryptophan with host arginine metabolism. The probiotic Lacticaseibacillus rhamnosus GG, when combined with tryptophan, enhances gut barrier integrity by upregulating argininosuccinate lyase (ASL), a key enzyme in arginine biosynthesis. The study also identifies ASL downregulation and increased serum argininosuccinate levels in a mouse model of colitis, pointing to a promising target for precision probiotic therapies.   Lacticaseibacillus rhamnosus GG-driven remodeling of arginine metabolism mitigates gut barrier dysfunction Jayson M. Antonio, Yue Liu, Panan Suntornsaratoon, Abigail Jones, Jayanth Ambat, Ajitha Bala, Joshua Joby Kanattu, Juan Flores, Sheila Bandyopadhyay, Ravij Upadhyay, Jagannatham Naidu Bhupana, Xiaoyang Su, Wei Vivian Li, Nan Gao, and Ronaldo P. Ferraris American Journal of Physiology-Gastrointestinal and Liver Physiology 2025 329:1, G162-G185

    9 min

  5. 07/24/2025

    Dietary Fibers and Gut Signals: How Fructooligosaccharides Modulate Colonic Motility via Calcium and 5-HT3 Receptors

    In this episode, we’re joined by coauthors Preedajit Wongkrasant and Keith A. Sharkey to discuss their recent publication, "Fructooligosaccharides slow colonic motility and activate myenteric neurons via calcium sensing and 5-HT3 receptors in the proximal colon." Calcium-sensing receptors are known to play an important role in gastrointestinal physiology. This study reveals a new function of fructooligosaccharides, a type of dietary fiber, in regulating colonic motility and activating the enteric nervous system. The effects are mediated through calcium-sensing and 5-HT3 receptors, providing new insights into gut–brain communication and potential therapeutic targets for gastrointestinal disorders.   Fructooligosaccharides slow colonic motility and activate myenteric neurons via calcium sensing and 5-HT3 receptors in the proximal colon Preedajit Wongkrasant, Laurie E. Wallace, Wallace K. MacNaughton, and Keith A. Sharkey American Journal of Physiology-Gastrointestinal and Liver Physiology 2025 328:6, G734-G745

    10 min

  6. 05/22/2025

    Unraveling Appetite: The Microbiota-Brain Connection Across the Lifespan

    In this episode, coauthors Gabriela Ribeiro, Marta P. Silvestre, Harriët Schellekens, and Cristina Cuesta-Marti discuss their recent review published in AJP-Gastrointestinal and Liver Physiology, titled "A menu for microbes: unraveling appetite regulation and weight dynamics through the microbiota-brain connection across the lifespan."   Appetite regulation is a complex and dynamic process influenced by behavioral, metabolic, and neurological factors — and increasingly, the gut microbiota. Our guests explore how the microbiota-gut-brain axis impacts appetite and obesity, highlighting how emerging omics tools and microbiota-targeted interventions may pave the way for precision treatments in nutrition and weight management. Tune in to hear how these researchers are bridging microbiology, neuroscience, and metabolism to better understand appetite across the lifespan.   A menu for microbes: unraveling appetite regulation and weight dynamics through the microbiota-brain connection across the lifespan Gabriela Ribeiro, Harriët Schellekens, Cristina Cuesta-Marti, Ivie Maneschy, Shámila Ismael, Amanda Cuevas-Sierra, J. Alfredo Martínez, Marta P. Silvestre, Cláudia Marques, André Moreira-Rosário, Ana Faria, Luis A. Moreno, and Conceição Calhau American Journal of Physiology-Gastrointestinal and Liver Physiology 2025 328:3, G206-G228

    10 min

  7. 04/14/2025

    Unraveling Fabry Disease: Lyso-Gb3’s Role in Gut Physiology

    In this episode, coauthors Cecilia Delprete, Friederike Uhlig, Marco Caprini, and Niall P. Hyland dive into their latest research titled "Characterization of Fabry disease-associated lyso-Gb3 on mouse colonic ion transport and motility." Fabry disease (FD) is a rare genetic disorder with wide-ranging effects across the body, including the gastrointestinal (GI) system—often one of the first to show symptoms. The team explores how the lipid molecule lyso-Gb3, known to accumulate in FD, affects colonic function using ex vivo techniques like Ussing chambers and organ baths. The conversation covers key findings: lyso-Gb3 significantly alters ion transport in the colon but doesn't affect motility or nerve responses, suggesting a complex mechanism behind GI symptoms in FD patients. Could this bring us closer to understanding—and eventually treating—the GI discomfort that burdens so many with Fabry disease? Tune in today!   Characterization of Fabry disease-associated lyso-Gb3 on mouse colonic ion transport and motility Cecilia Delprete, Friederike Uhlig, Marco Caprini, and Niall P. Hyland American Journal of Physiology-Gastrointestinal and Liver Physiology 2024 327:6, G810-G817

    12 min

  8. 03/13/2025

    Got Guts: A Chance to Put Liver Biopsy Back to Its Former Glory?

    In this episode, coauthors Camilla Venturin and Luca Fabris delve into their editorial titled "Machine Learning Application to Histology for the Study of Cholangiopathies (BiliQML): A Chance to Put Liver Biopsy Back to Its Former Glory?" The episode explores groundbreaking research by Dominick Hellen and colleagues on the limitations of current histological techniques in studying cholangiocytes and the biliary tree. Historically, the study of these cells has been constrained by outdated and error-prone methodologies, like two-dimensional cell counting or complex three-dimensional imaging that fails to provide reliable quantification. Enter BiliQML, a novel machine learning model that promises to revolutionize this field. This episode breaks down how BiliQML quantifies biliary forms using anti-Keratin 19 antibody-stained whole slide images, providing a far more accurate and scalable approach. With an impressive F-score of 0.87, the model's application across a variety of cholangiopathy models, including genetic, surgical, toxicological, and therapeutic, showcases its sensitivity and robustness. The episode reveals how this cutting-edge technology opens new doors for both clinical and basic-science researchers in the field of cholangiopathies. Tune in to discover how machine learning is bringing liver biopsy back to the forefront of research.   Machine learning application to histology for the study of cholangiopathies (BiliQML): A chance to put liver biopsy back to its former glory? Camilla Venturin and Luca Fabris American Journal of Physiology-Gastrointestinal and Liver Physiology 2024 327:6, G733-G736

    7 min
See All (50)

About

Podcasts of the American Journal of Physiology-Gastrointestinal and Liver Physiology

Information